With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

An Alzheimer's drug that had been hailed as a major breakthrough may actually increase patients' chance of dying, according to new research. The treatment, lecanemab, was found to triple the risk ...

A new blood test that can detect Alzheimer's disease in mere minutes has the potential to revolutionise treatment.

Oct. 30, 2024 — An important new study has demonstrated ... researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...

Research led by the University of Michigan has provided compelling evidence that could solve a fundamental mystery in the makeup of fibrils that play ...

A breakthrough AI model analyzes diverse data to reveal faster Alzheimer’s progression in Black females ... uncovering ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

Blood-based diagnostic tests are gaining traction as a potential method for the early detection of Alzheimer’s disease, ...